01 5Ultomiris
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 1,077
2019 Revenue in Millions : 339
Growth (%) : 218
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 688
2020 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 1,965
2021 Revenue in Millions : 688
Growth (%) : 186
Main Therapeutic Indication : Hematology
Currency : USD
2023 Revenue in Millions : 2,965
2022 Revenue in Millions : 1,965
Growth (%) : 51
Main Therapeutic Indication : Hematology
Currency : USD
2019 Revenue in Millions : 339
2018 Revenue in Millions : 0
Growth (%) : New launch
LOOKING FOR A SUPPLIER?
